Toluene alters appetite, NPY, and galanin immunostaining in the rat hypothalamus

Neurotoxicology and Teratology

Volumn 26, Issue 2, 2004, Pages 195-200

  Morón, Lena ^a   Pascual, Jesús ^a   Portillo, María P ^a   Casis, Luis ^a   Macarulla, M Teresa ^a   Abecia, Luis C ^a   Echevarría, Enrique ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Appetite; Galanin; NPY; Rat hypothalamus; Toluene

Indexed keywords

GALANIN; NEUROPEPTIDE Y; NEUROTOXIN; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; APPETITE DISORDER; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; THALAMUS MIDLINE NUCLEUS;

ANIMALS; APPETITE; BEHAVIOR, ANIMAL; BODY WEIGHT; EATING; GALANIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; STATISTICS, NONPARAMETRIC; TOLUENE;

EID: 1542328261     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2003.10.010     Document Type: Article

References (36)

1. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., Polack J.M. Neuropeptide Y distribution in the rat brain. Science. 4613:1983;877-879.
2. Assimacopoulos-Jeannet F., Moinat M., Muzzin P., Colomb C., Jeanrenaud B., Girardier L., Giacobino J.P., Seydoux J. Effects of a peroxisome proliferator on beta-oxidation and overall energy balance in obese (fa/fa) rats. Am. J. Physiol. 260:1991;R278-R283.
3. Beck B. Neuropeptides and obesity. Nutrition. 16:2000;916-923.
4. Bergonzelli G.E., Pralong F.P., Glauser M., Cavadas C., Grouzmann E., Gaillard R.C. Interplay between galanin and leptin in the hypothalamic control of feeding via corticotropin-releasing hormone and neuropeptide Y. Diabetes. 50:2001;2666-2672.
5. Billington C.J., Briggs J.E., Harker S., Grace M., Levine A.S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 266:1994;R1765-R1770.
6. Bina K.G., Cincotta A.H. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain and hyperglycemia in ob/ob mice. Neuroendocrinology. 71:2000;68-78.
7. Ceccatelli S., Ericsson M., Hökfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular of the paraventricular nucleus. Neuroendocrinology. 3:1989;309-323.
8. Crawley J.N. The role of galanin in feeding behavior. Neuropeptides. 33(5):1999;369-375.
9. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., Bloom S.R. The effects of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 3:1999;R7-R12.
10. Engelke M., Diehl H., Tahti H. Effects of toluene and n-hexane on rat synaptosomal membrane fluidity and integral enzyme activities. Pharmacol. Toxicol. 71:1992;343-347.
11. Flanagan R.J., Ives R.J. Volatile substance abuse. Bull. Narc. 46:1994;49-78.
12. Gehlert D.R. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides. 5:1999;329-338.
13. Gospe S.M., Zhou S.S. Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex. Pediatr. Res. 47:2000;362-368.
14. Gospe S.M., Zhou S.S., Saeed D.B., Zeman F.J. Development of a rat model of toluene abuse embryopathy. Pediatr. Res. 40:1996;82-87.
15. Halford J.C., Blundell J.E. Separate systems for serotonin and leptin in appetite control. Ann. Med. 32:2000;222-232.
16. Hökfelt T., Broberger C., Díez M., Xu Z.Q., Shi T., Kopp J., Zhang X., Holmberg K., Landry M., Koistinaho J. Galanin and NPY, two peptides with multiple putative roles in the nervous system. Horm. Metab. Res. 31(5):1999;330-334.
17. Hsieh G.C., Sharma R.P., Parker R.D. Subclinical effects of ground water contaminants: IV. Effects of repeated oral exposure to combinations of benzene and toluene on regional brain monoamine metabolism in mice. Arch. Toxicol. 64:1990;669-676.
18. Hsieh G.C., Sharma R.P., Parker R.D., Coulombe R.A. Jr. Evaluation of toluene exposure via drinking water on levels of regional brain biogenic monoamines and their metabolites in CD-1 mice. Ecotoxicol. Environ. Saf. 20:1990;175-184.
19. Kasser T.R., Harris R.B., Martin R.J. Level of satiety: in vitro energy metabolism in brain during hypophagic and hyperphagic body weight recovery. Am. J. Physiol. 257:1989;R1322-R1327.
20. Kim D.B., Lee J.K., Jung K.J., Yoon Y.P. Effects of toluene inhalation on the concentrations of the brain monoamines and metabolites. J. Toxicol. Public Health. 14:1998;495-500.
21. Kishi R., Harabuchi Y., Katakura Y., Ikeda T., Miyake H. Neurobehavioral effects of chronic occupational exposure to organic solvents among Japanese industrial painters. Environ. Res. 62:1993;303-313.
22. Kuo D.Y. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats. J. Biomed. Sci. 9:2002;126-132.
23. Leibowitz S.F. Brain peptides and obesity: pharmacologic treatment. Obes. Res. 3:1995;573S-589S.
24. Leibowitz S.F. Differential functions of hypothalamic galanin cell grows in the regulations of eating and body weight. Ann. N.Y. Acad. Sci. 863:1998;206-220.
25. Leibowitz S.F., Weiss G.F., Suh J. Medium hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behaviour. Pharmacol. Biochem. Behav. 37:1990;735-742.
26. Menéndez J.A., Atrens D.M., Leibowitz S.F. Metabolic effects of galanin injections into the paraventricular nucleus of the hypothalamus. Peptides. 13:1992;323-327.
27. Miller M.A., Kolb P.E., Leverenz J.B., Peskind E.R., Raskind M.A. Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease. J. Neurochem. 73(5):1999;2028-2036.
28. Nagase H., Bray G.A., York D.A. Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res. 709:1996;44-50.
29. Pappolla M., Penton R., Weiss H.S., Miller C.H. Jr., Sahenk Z., Autilio-Gambetti L., Gambetti P. Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size. Brain Res. 424:1987;272-280.
30. Smith B.K., York D.A., Bray G.A. Chronic cerebroventricular galanin does not induced sustained hyperphagia and obesity. Peptides. 15:1994;1267-1272.
31. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 269:1982;659-660.
32. Vickers S.P., Dourish C.T., Kennett G.A. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology. 41:2001;200-209.
33. Von Euler G., Fuxe K., Bondy S.C. Ganglioside GM1 prevents and reverses tolene-induced increases in membrane fluidity and calcium levels in rat brain synaptosomes. Brain Res. 508:1990;210-214.
34. Von Euler G., Ogren S.O., Bondy S.C., Mckee M., Warner M., Gustafsson J.A., Eneroth P., Fuxe K. Subacute exposure to low concentrations of toluene affects dopamine-mediated locomotor activity in the rat. Toxicology. 67:1991;333-349.
35. Wang J., Akabayashi A., Yu H.J., Dourmashkin J., Alexander J.T., Silva I., Lighter J., Leibowitz S.F. Hypothalamic galanin: control by signals of fat metabolism. Brain Res. 804:1998;7-20.
36. Zabedah M.Y., Razak M., Zakiak I., Zuraidah A.B. Profile of solvent abusers (glue sniffers) in East Malaysia. Malays. J. Pathol. 23:2001;105-109.